Escitalopram (brand name Cipralex, though often prescribed as generic) is a selective serotonin reuptake inhibitor (SSRI) antidepressant licensed in the UK for treating major depressive disorder, generalised anxiety disorder, panic disorder, social anxiety disorder, and obsessive-compulsive disorder
Mathur is double board certified in obesity medicine and internal medicine and is also a founder of Lifelong Weight Loss and a nutrition consultant for the Houston Rockets
Obesity, 33 (12), 22962303
Obtaining injections outside regulated NHS settings may involve inappropriate dosing, lack of monitoring, non-sterile technique, and unnecessary financial cost without clinical benefit
The metabolic benefits for patients with obesity, type 2 diabetes, and cardiovascular risk are well established and continue to expand with ongoing research